APA (7th ed.) Citation

Papageorgiou, S. G., Kotsianidis, I., Kontos, C. K., Symeonidis, A., Galanopoulos, A., Hatzimichael, E., . . . Pappa, V. (2018). Body mass index and relative dose intensity does not affect the response and outcome of high-risk MDS patients treated with azacytidine. Results from the Hellenic (Greek) MDS study group. Leukemia Research, 71, 55. https://doi.org/10.1016/j.leukres.2018.07.004

Chicago Style (17th ed.) Citation

Papageorgiou, Sotirios G., et al. "Body Mass Index and Relative Dose Intensity Does Not Affect the Response and Outcome of High-risk MDS Patients Treated with Azacytidine. Results from the Hellenic (Greek) MDS Study Group." Leukemia Research 71 (2018): 55. https://doi.org/10.1016/j.leukres.2018.07.004.

MLA (9th ed.) Citation

Papageorgiou, Sotirios G., et al. "Body Mass Index and Relative Dose Intensity Does Not Affect the Response and Outcome of High-risk MDS Patients Treated with Azacytidine. Results from the Hellenic (Greek) MDS Study Group." Leukemia Research, vol. 71, 2018, p. 55, https://doi.org/10.1016/j.leukres.2018.07.004.